The central concept is the “maximum increase” for an item. Under subsections 10ACA(7A) and 10ADA(8A) of the Health Insurance Act, the Minister may determine that certain items are subject to a cap on the additional Medicare benefit payable under the EMSN. That cap is the “maximum increase” over the normal benefit. The Determination lists the items and the applicable cap. The “Schedule fee” is defined in subsection 8(1A) of the Act and is the fee set out in the Medicare Benefits Schedule for that item. The Schedule fee is the base amount upon which the normal Medicare benefit is calculated (usually 85% of the fee, or 75% for some inpatient services). For the EMSN, the additional benefit is calculated with reference to the gap between the Schedule fee and the actual fee charged, but it is then capped by the amount in this Determination. If the calculated additional benefit would exceed the cap, only the cap is paid; the patient bears the excess.

The Determination uses three types of caps. Fixed-dollar amounts are self-explanatory: the EMSN benefit for that item cannot increase by more than that many dollars, regardless of the Schedule fee or the actual charged amount. Percentage caps, e.g., “65 percent of the Schedule fee for the item”, mean the additional benefit cannot exceed 65% of whatever the Schedule fee is at the time of service. If the Schedule fee rises, the cap rises proportionally. Hybrid caps, e.g., “300 percent of the Schedule fee for that item or $500.00 for that item whichever represents the lesser amount”, impose a double limit: the cap is the lower of the percentage amount and the fixed dollar amount. This protects the scheme from very large benefits on high-fee items while still providing a meaningful cap for lower-fee items. The Determination applies these caps to specific items or groups of items. Groups are defined in the general medical services table (e.g., Groups A1 to A46, M3 to M19, O1, T6) and cover broad categories such as general practice attendances, specialist attendances, and medical procedures. The effect is that most out-of-hospital medical services have a maximum EMSN benefit of either a fixed sum or a percentage, but never unlimited.

The Determination affects everyone involved in the Medicare system where out-of-hospital services are provided and the patient’s out-of-pocket costs exceed the EMSN threshold. The primary groups are patients, medical practitioners, private health insurers, and administrators. For patients who have high medical expenses in a calendar year and who rely on the EMSN to reduce the cost of ongoing treatment, the caps directly limit how much extra benefit they can receive. If a doctor charges well above the Schedule fee, the EMSN benefit may be capped well below the gap, leaving the patient to pay the difference. This is particularly relevant for patients with chronic conditions requiring frequent or expensive services, such as obstetrics, assisted reproduction, surgery, and diagnostic imaging.

Medical practitioners and their billing staff must be aware of the caps when setting fees and advising patients. A practitioner who charges a fee expecting the EMSN to cover a large portion may find the patient is liable for a bigger gap than anticipated, potentially creating collection difficulties or disputes. The caps also affect how doctors negotiate fees with patients; knowing the maximum EMSN benefit for an item informs the maximum out-of-pocket cost that will be subsidised. Private health insurers are indirectly affected because the EMSN interacts with hospital cover and ancillary benefits, especially for services that attract a Medicare benefit. Administrators at Medicare and the Department of Health and Aged Care must ensure the correct cap is applied to each claim, and the caps must be updated when Schedule fees change or when new items are added.

The determination also affects suppliers of services listed in the diagnostic imaging services table, such as radiology practices, where numerous items have caps set at either a fixed dollar or a percentage (e.g., 80% of the Schedule fee for certain nuclear medicine items). Any change to the caps directly alters the effective subsidy for patients and the net revenue for providers. Finally, the determination indirectly affects taxpayers, because higher caps increase total EMSN outlays, while tighter caps reduce government expenditure but increase patient financial risk.

The Determination does not impose duties directly on individuals; it is a legislative instrument that binds the decision-making of the Medicare claims administrator. The key duty is on the Chief Executive of Medicare (or delegate) to apply the correct maximum increase when processing an EMSN benefit claim for a service that falls within the items listed. For each item in the tables, the administrator must calculate the additional benefit as the lesser of: (a) the amount by which the patient’s out-of-pocket cost for that service exceeds the normal Medicare benefit, and (b) the maximum increase specified in the Determination. If the patient’s out-of-pocket cost is $500 but the maximum increase is $300, only $300 of additional benefit is payable. The patient retains the right to receive that capped benefit, provided they have exceeded the EMSN threshold for the year.

For practitioners, there is a practical duty to inform patients about likely out-of-pocket costs, especially if the EMSN cap may be binding. While the Determination imposes no legal duty on practitioners, they may face contractual or ethical obligations to disclose the effect of caps. Patients have a right to know the maximum EMSN benefit for a proposed service, and they can request this information from Medicare or the practitioner. However, the Determination itself does not create private rights of action; if the administrator incorrectly applies a cap, the patient’s remedy is through Medicare review mechanisms or administrative law.

The Determination also affects the rights of patients to access the EMSN for certain items. For example, items 75002 and 75005 (likely assisted reproductive technology services) have a hybrid cap of 300% of the Schedule fee or $500, whichever is less. This means that for a high-fee procedure, the additional EMSN benefit is capped at $500, limiting the subsidy even if the patient’s out-of-pocket costs exceed that. The right to the EMSN benefit exists only to the extent provided by the Determination; there is no right to an uncapped benefit. The Determination is reviewed and updated periodically, but the affected parties have no right to input into the specific caps, other than through the usual consultation processes for legislative instruments.

The Determination itself does not contain penalty provisions; penalties arise under the Health Insurance Act and other relevant statutes for matters such as false claims or misrepresentations. However, the Determination is enforceable indirectly: if a practitioner or patient intentionally misrepresents the service provided in order to obtain a higher EMSN benefit than allowed under the caps (e.g., billing under a different item with a higher cap), they may be liable for offences under Part II of the Act, including false or misleading statements. Penalties for such offences can include fines and, for practitioners, referral to the Professional Services Review scheme, which can result in reprimands, sanctions, or exclusion from Medicare.

The maximum increases are mandatory; the administrator has no discretion to exceed them. If a claim is processed incorrectly and a higher benefit is paid, the overpayment is recoverable as a debt due to the Commonwealth under section 129AAA of the Health Insurance Act. Recovery actions may include garnishment of future Medicare benefits, offsetting against tax refunds, or legal proceedings. The Determination thus acts as a control mechanism that, if bypassed, triggers standard enforcement measures. For the practitioner who assists a patient to circumvent the caps by manipulating item numbers or fee schedules, the Professional Services Review could investigate and recommend that the Director impose a sanction such as a reprimand, suspension, or disqualification from billing Medicare.

Given that the Determination is a legislative instrument, any amendments must be registered and published. Failure to apply the correct version could result in administrative errors, but not criminal liability for the processor if done in good faith. The risk of enforcement falls most heavily on those who attempt to defraud the EMSN by exploiting the caps. There are no specific penalties tied to the dollar amounts in the Determination itself; the relevant penalties are those set out in the Act for non-compliance with Medicare rules generally.

This Determination is made under the Health Insurance Act 1973, specifically section 10B. It must be read together with sections 10ACA, 10ADA, and 10B of that Act, which establish the legal framework for the EMSN caps. The Determination supplements the Act by specifying the numerical values for those caps. It also interacts with the Determination under subsection 3C(1) of the Act, which lists additional medical services (e.g., allied health and assisted reproductive technology) that are covered by the general medical services table or a separate determination. Where such items are listed in section 4(5) of the Determination (e.g., items 75002, 75005, and others), they are also subject to the caps.

The Determination interacts with the Medicare Benefits Schedule (MBS) as published from time to time. The MBS determines the Schedule fee for each item, and because many caps are expressed as percentages of that fee, the actual dollar cap changes whenever the fee changes. This means the Determination is not self-executing in dollar terms for percentage-based caps; it depends on the latest MBS. Administrators must use the current Schedule fee when calculating the cap. The Determination also interacts with the Health Insurance (General Medical Services Table) Determination and the Health Insurance (Diagnostic Imaging Services Table) Determination, which prescribe the items themselves. Although those tables are incorporated by reference, this Determination does not amend them; it only applies caps to existing items.

The Determination does not affect the operation of the Private Health Insurance Act 2007, but it influences the out-of-pocket amounts that private health insurers may cover. Insurers often use the gap between the Medicare benefit and the Schedule fee as a basis for their own benefits; a capped EMSN benefit reduces the patient’s out-of-pocket, which may in turn affect insurer liability. The Determination does not override state or territory health legislation; it is strictly a Commonwealth Medicare instrument. It does not interact with the National Health Act 1953, which governs pharmaceuticals, but it may affect patients who use both medical and pharmaceutical safety nets.

The Determination must be read consistently with the Legislation Act 2003, which governs registration, tabling, and sunsetting of legislative instruments. As a determination made under the Act, it is subject to disallowance by either House of Parliament. The current version was made in 2017; it may have been amended by subsequent instruments, which would be incorporated by reference. The source text provided shows no amendment history, but users must verify the latest compilation.

The source text provided is the original Health Insurance (Extended Medicare Safety Net) Determination 2017 as it appears on its face. It does not include any amending instruments or a note about amendments. However, as a legislative instrument, it may have been amended since 2017. The Department of Health and Aged Care regularly updates EMSN caps to reflect changes in the MBS and to manage budgetary outlays. Typical amendments include adding new MBS items, removing items, adjusting fixed dollar amounts (often by indexation), and modifying percentage caps. For example, from 2017 to 2024, there have been several amending determinations such as the Health Insurance (Extended Medicare Safety Net) Amendment Determination 2019, 2021, 2022, etc. These amendments are not reproduced in the source, so the text provided likely does not reflect the current law. Practitioners should not rely on the 2017 values for current claims; they must obtain the latest Federal Register of Legislation version.

The original determination commenced on 1 July 2017, replacing earlier versions. The fixing of dollar amounts and percentages is a snapshot in time. The absence of amendment history in the source means we cannot comment on the specific changes, but we can note that the instrument is subject to periodic review and amendment. The Department typically updates the caps in line with MBS indexation and policy decisions, and may create new tables for items added to the MBS. Users should check whether the item numbers listed are still current and whether the caps have been adjusted. Fixed dollar amounts are particularly prone to erosion by inflation; unless amended, they become more restrictive over time, reducing the real value of the EMSN benefit for those items.

The source text does not mention any litigation concerning this Determination. There is no incorporated case law or reference to court decisions. Given that the Determination is a legislative instrument that sets administrative caps, it is unlikely to be the subject of direct challenge unless someone argues that the caps are ultra vires the Health Insurance Act or are not properly authorised. However, administrative law challenges to Medicare decisions involving the EMSN caps are possible. For example, a patient who believes the cap was miscalculated might apply for judicial review of a decision not to pay a higher benefit. But the Determination itself would be the rule applied, not the target of the challenge.

There is also a possibility of litigation over the proper interpretation of the caps, particularly for percentage-based caps where the Schedule fee definition or fee for a bundled service is contested. However, the source provides no such history. The Determination is a technical instrument that typically flies under the litigation radar; disputes are more likely to be resolved through Medicare’s internal review or the Administrative Appeals Tribunal. The lack of litigation history in the source suggests that the caps have not provoked significant controversy, though that could change if the government tightens caps further. Users should not assume there is no related case law; a separate search of the Federal Court and Tribunal databases would be necessary.

Several features of the Determination can trip up even experienced practitioners. The first is the hybrid cap “300 percent of the Schedule fee for that item or $500.00 for that item whichever represents the lesser amount”. This appears in subsections 4(3), (3A), (3B), (4), and (5) for many items and groups. The operation is that for each service, the cap is the lower of (a) three times the Schedule fee, and (b) $500. As a result, for items with a Schedule fee above about $167, the $500 cap binds; for items with a lower Schedule fee, the percentage cap binds. This creates a step function that some calculators may not apply correctly if they only use the percentage or only the dollar amount.

The second gotcha is that the Determination applies to items “in a determination made under subsection 3C(1) of the Act”. This is an obscure cross-reference. The subsection 3C(1) determination covers services that are not in the general medical services table or the diagnostic imaging services table but are still Medicare-eligible, such as certain allied health services and assisted reproductive technology items. Those items are listed in section 4(5) and in various groups (e.g., Group O1, which covers obstetrics, or Groups M3-M32 which cover diagnostic imaging services). If a practitioner uses an item from a 3C(1) determination that is not listed in section 4(5), it may be covered by a group cap if it falls within a listed group. But not all 3C(1) items are covered; the determination only applies to those items that are either individually listed or fall within a listed group. For example, item 880 in Group A8 is excluded (see subsection 4(3A): “except item 297” for Group A8; actually 3A says except item 297? Wait: “all items in Group A8 (except item 297)” - so item 297 is not subject to the cap. Similarly item 880 in Group A15 is excepted. Practitioners must check the specific exclusions.

Another trap: the percentage caps are expressed as a percentage of the Schedule fee for the item. If the Schedule fee changes (due to indexation or a policy change), the dollar amount of the cap changes automatically. A practitioner who quotes a patient a fixed dollar amount based on an old fee schedule may underestimate the cap. Moreover, some items have caps expressed as “65 percent of the Schedule fee” while others have “80 percent” or “15 percent”. A simple mistake in applying the percentage can lead to overpayment or underpayment.

Fixed dollar amounts (e.g., $13.80, $27.30) appear to be low. For items like 82100 (ear, nose and throat procedures) the cap is only $27.30. Given that EMSN benefits are paid only after the annual threshold is reached (currently over $600 for most patients), these low caps mean that for many services, the additional EMSN benefit will be minimal. That may surprise patients who expect the EMSN to significantly reduce their costs.

Compliance with this Determination is primarily the responsibility of Medicare claims processors and the Department. However, healthcare providers and patients also have practical steps to ensure accurate billing and appropriate expectation-setting. The most critical step for a provider is to identify the correct MBS item for the service and then look up the applicable maximum increase from the current version of this Determination (not the 2017 base version). Because the Determination can be amended several times a year, relying on a saved PDF can lead to errors. The Department publishes a consolidated version on the Federal Register of Legislation, and the MBS Online tool often incorporates EMSN caps in its fee estimates.

For percentage-based caps, providers must know the current Schedule fee. The Schedule fee changes on 1 July each year (and sometimes at other dates due to restructures). The percentage is then applied against that fee. If the cap is a hybrid (e.g., 300% or $500), calculate both, and the cap is the lower amount. For fixed-dollar caps, the dollar figure is the cap irrespective of fee changes until amended. Providers should also check for any exclusions or special conditions, such as items 297 and 880 which are specifically excluded from certain group caps.

When setting a fee, a practitioner can use the cap to estimate the maximum EMSN benefit the patient might get. This informs any discussion about out-of-pocket costs. If the fee is high, the cap may mean the patient still has significant gap. The practitioner should document that the patient was informed of the likely gap to reduce later disputes. From an accounting perspective, the practice management software should be configured to look up the correct cap, but manual verification is prudent.

For patients, the best way to comply is to check the Medicare Benefits Schedule and the EMSN cap for a proposed service before agreeing to a fee. Patients can ask the provider or call Medicare. They should also maintain records of their out-of-pocket costs throughout the year to track whether they have reached the EMSN threshold. Patients should be aware that the cap limits the additional benefit, so even after exceeding the threshold, they may still pay substantial gaps.

Administrators of medical billing systems must ensure that their claim processing software is updated with each new version of the Determination. Incorrect application of caps can result in overpayments that must be recovered, causing administrative burden and potential penalties. A thorough system audit should be performed whenever a new EMSN Determination is registered. This includes checking all item numbers to see if they have been added, removed, or reassigned to a different cap.

Finally, anyone involved in advising on Medicare compliance should monitor the Department's website for consultation papers or exposure drafts of new determinations, because caps can change without much public notice. The compliance burden is not onerous for most parties, but ignorance of the caps can lead to financial surprises for patients and reputational risk for providers.